Hepatic and renal effects of oral stingless bee honey in a streptozotocin-induced diabetic rat model

Table 3 Biochemical evaluation of liver function in response to different treatments over 12 d

Group	Analytes
	Albumin (g/L)	Total	ALT (U/L)	AST (U/L)	ALP (U/L)
		Protein (g/L)
Non-diabetic	32.00 ± 1.10	54.25 ± 0.75	58.00 ± 5.40	110.40 ± 12.14	134.60 ± 5.59
Untreated diabetic	28.50 ± 0.65	49.67 ± 2.19	75.50 ± 33.18	121.00 ± 7.44	162.00 ± 25.65
Stingless bee honey	29.33 ± 0.71	52.67 ± 2.32	64.20 ± 0.80	108.30 ± 11.46	131.70 ± 23.92
Metformin	28.40 ± 0.51a	50.33 ± 0.33	69.00 ± 7.41	110.30 ± 6.921	126.70 ± 14.84
Stingless bee honey plus metformin	29.50 ± 0.87	53.67 ± 1.20	71.50 ± 15.50	116.00 ± 11.41	149.30 ± 7.75

^aP < 0.05 compared with non-diabetic.

Data were analyzed using one-way ANOVA, followed by Tukey’s post-test. Data were expressed as mean + SEM. ALT: Alanine transaminase; AST: Aspartate transaminase; ALP: Alkaline phosphatase.